The shimada index is a histopathologic classification system, widely used for neuroblastoma
, developed by h.
Shimada. Using the shimada criteria, kids with neuroblastoma can be grouped into a favorable or unfavorable category. It's based on the presence or absence of cell stroma, the degree of differentiation, and the mitosis-karyorrhexis index.